Found 15 matching trials
Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day. PHASE4 LCP-Tacro is an extended-release formulation of tacrolimus designed for onc...
Show More Location
Nephrology Department- Hospital Universitari Bellvtge
Learn More & Join Trial
Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients PHASE2 A three sequence, open-label, multi-center, prospective, study in stable ki...
Show More Location
University of Cincinnati
Learn More & Join Trial
LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis PHASE2 An open-label, multi-center, prospective, randomized study to evaluate the ...
Show More Location
Mayo Clinic - Phoenix
Learn More & Join Trial
Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx PHASE3 This study will evaluate the efficacy and safety of LCP-Tacro (tacrolimus) ...
Show More Location
Clinical Site 1020
Learn More & Join Trial
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus PHASE4 The investigators believe that the pharmacological properties of Envarsus®,...
Show More Location
Nantes University Hospital
Learn More & Join Trial
Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant PHASE2 The purpose of this study is to evaluate the pharmacokinetics of LCP-Tacro ...
Show More Location
Clinical Investigative Site 000015
Learn More & Join Trial
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO) PHASE3 This study will evaluate and measure symptomatic hand tremor in stable kidn...
Show More Location
Clinical Investigative Site 006
Learn More & Join Trial
Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily. PHASE3 Open label, prospective, single-center, randomized, two sequence, three per...
Show More Location
University of Illinois, Chicago
Learn More & Join Trial
Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily PHASE3 This is 2-armed parallel group, prospective, randomized, open-label, multic...
Show More Location
California Institute of Renal Research/ Sharp Memorial
Learn More & Join Trial
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus PHASE3 The overall aim of the study is to prospectively investigate the impact of ...
Show More Location
Northwestern University
Learn More & Join Trial